Rhenman--Partners-Asset-Management-Ab

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
94
Total Value
869997756
Accession Number
0001213900-25-042939
Form Type
13F-HR
Manager Name
Rhenman--Partners-Asset-Management-Ab
Data Enrichment
98% identified
92 identified2 unidentified

Holdings

94 positions • $870.0M total value
Manager:
Search and click to pin securities to the top
Nurix Therapeutics, Inc.
Shares:249.3K
Value:$3.0M
% of Portfolio:0.3% ($3.0M/$870.0M)
Merck & Co., Inc.
Shares:33.0K
Value:$3.0M
% of Portfolio:0.3% ($3.0M/$870.0M)
Arcellx, Inc.
Shares:43.5K
Value:$2.9M
% of Portfolio:0.3% ($2.9M/$870.0M)
Inspire Medical Systems, Inc.
Shares:16.0K
Value:$2.5M
% of Portfolio:0.3% ($2.5M/$870.0M)
IONIS PHARMACEUTICALS INC
Shares:81.0K
Value:$2.4M
% of Portfolio:0.3% ($2.4M/$870.0M)
Viking Therapeutics, Inc.
Shares:100.0K
Value:$2.4M
% of Portfolio:0.3% ($2.4M/$870.0M)
Dianthus Therapeutics, Inc. /DE/
Shares:126.6K
Value:$2.3M
% of Portfolio:0.3% ($2.3M/$870.0M)
Privia Health Group, Inc.
Shares:98.2K
Value:$2.2M
% of Portfolio:0.3% ($2.2M/$870.0M)
IOVANCE BIOTHERAPEUTICS, INC.
Shares:647.8K
Value:$2.2M
% of Portfolio:0.2% ($2.2M/$870.0M)
Xencor Inc
Shares:195.8K
Value:$2.1M
% of Portfolio:0.2% ($2.1M/$870.0M)
BRUKER CORP
Shares:42.3K
Value:$1.8M
% of Portfolio:0.2% ($1.8M/$870.0M)
MoonLake Immunotherapeutics
Shares:45.0K
Value:$1.8M
% of Portfolio:0.2% ($1.8M/$870.0M)
Esperion Therapeutics, Inc.
Shares:1.1M
Value:$1.5M
% of Portfolio:0.2% ($1.5M/$870.0M)
Inmune Bio, Inc.
Shares:178.3K
Value:$1.4M
% of Portfolio:0.2% ($1.4M/$870.0M)
Denali Therapeutics Inc.
Shares:100.0K
Value:$1.4M
% of Portfolio:0.2% ($1.4M/$870.0M)
Vir Biotechnology, Inc.
Shares:200.0K
Value:$1.3M
% of Portfolio:0.1% ($1.3M/$870.0M)
Alkermes plc.
Shares:39.0K
Value:$1.3M
% of Portfolio:0.1% ($1.3M/$870.0M)
Kura Oncology, Inc.
Shares:195.0K
Value:$1.3M
% of Portfolio:0.1% ($1.3M/$870.0M)
ARVINAS, INC.
Shares:183.0K
Value:$1.3M
% of Portfolio:0.1% ($1.3M/$870.0M)
AMGEN INC
Shares:4.0K
Value:$1.2M
% of Portfolio:0.1% ($1.2M/$870.0M)